E-ISSN 2218-6050 | ISSN 2226-4485
 

Original Article


Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo.


Cited By:9

Abstract
Hypercortisolism induces a state of insulin resistance that can occur concurrently with fasting hyperglycaemia, dyslipidaemia and diabetes mellitus. Metformin reduces hepatic glucose production and insulin resistance of the skeletal muscle and adipose tissue. The aim of this study was to evaluate the effects of metformin on the control of metabolic disorders of dogs with hyperadrenocorticism (HAC). Twenty-three dogs with HAC were randomly divided into two groups, consisting of a control group and a metformin group (10 mg metformin/kg/12 h). Both groups received the same treatment for HAC. At baseline and 3 months, blood glucose, total cholesterol, triglyceride and insulin concentrations, in addition to urinary cortisol:creatinine ratio, Homeostatic Model Assessment (HOMA) for insulin sensitivity and β-cell function were measured. Dogs treated with metformin showed significantly reduced glycaemia, cholesterolaemia and triglyceridaemia. They also presented reduced hyperinsulinism and insulin resistance, as well as improved pancreatic β-cell function. The implementation of metformin as an adjuvant therapy is effective for the normalisation of metabolic disorders of dogs with HAC.

Key words: metfomin, hyperadrenocorticism, insulin resistance, dyslipidaemia


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Diego D Miceli
Articles by Patricia Noemi Vidal
Articles by María Fernanda Cabrera Batter
Articles by Omar Pignataro
Articles by Victor Alejandro Castillo
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo. Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism. Open Vet J. 2018; 8(2): 193-199. doi:10.4314/ovj.v8i2.13


Web Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo. Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism. https://www.openveterinaryjournal.com/?mno=282461 [Access: December 07, 2024]. doi:10.4314/ovj.v8i2.13


AMA (American Medical Association) Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo. Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism. Open Vet J. 2018; 8(2): 193-199. doi:10.4314/ovj.v8i2.13



Vancouver/ICMJE Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo. Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism. Open Vet J. (2018), [cited December 07, 2024]; 8(2): 193-199. doi:10.4314/ovj.v8i2.13



Harvard Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo (2018) Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism. Open Vet J, 8 (2), 193-199. doi:10.4314/ovj.v8i2.13



Turabian Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo. 2018. Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism. Open Veterinary Journal, 8 (2), 193-199. doi:10.4314/ovj.v8i2.13



Chicago Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo. "Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism." Open Veterinary Journal 8 (2018), 193-199. doi:10.4314/ovj.v8i2.13



MLA (The Modern Language Association) Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo. "Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism." Open Veterinary Journal 8.2 (2018), 193-199. Print. doi:10.4314/ovj.v8i2.13



APA (American Psychological Association) Style

Diego D Miceli, Patricia Noemi Vidal, María Fernanda Cabrera Batter, Omar Pignataro, Victor Alejandro Castillo (2018) Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism. Open Veterinary Journal, 8 (2), 193-199. doi:10.4314/ovj.v8i2.13